AAME
Atlantic American Corporation [AAME] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AAME Stock Summary
Top 10 Correlated ETFs
AAME
Top 10 Correlated Stocks
AAME
In the News
AAME Financial details
Company Rating
Sell
Market Cap
44.68M
Income
-171K
Revenue
186.79M
Book val./share
5.26
Cash/share
1.47
Dividend
0.02
Dividend %
0.78%
Employees
154
Optionable
No
Shortable
Yes
Earnings
28 Jun 2024
P/E
16.77
Forward P/E
-
PEG
-1.25
P/S
0.28
P/B
0.53
P/C
1.33
P/FCF
10.27
Quick Ratio
23.46
Current Ratio
7.92
Debt / Equity
0.35
LT Debt / Equity
0.34
-
-
EPS (TTM)
-0.02
EPS next Y
-
EPS next Q
-
EPS this Y
-115.22%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-15.15%
Revenue last 5Y
-1.18%
Revenue Q/Q
4.83%
EPS Q/Q
-235.3%
-
-
-
-
SMA20
-24.19%
SMA50
-21.35%
SMA100
19.32%
Inst Own
4.18%
Inst Trans
0.77%
ROA
1%
ROE
3%
ROC
0.01%
Gross Margin
100%
Oper. Margin
3%
Profit Margin
2%
Payout
26%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.49-3.0
52W High
-35%
52W Low
+95%
RSI
26.53
Rel Volume
0.49
Avg Volume
7.05K
Volume
3.49K
Perf Week
-7.58%
Perf Month
-26.14%
Perf Quarter
0.52%
Perf Half Y
12.72%
-
-
-
-
Beta
0.334
-
-
Volatility
0.13%, 0.32%
Prev Close
-0.51%
Price
1.95
Change
-8.02%
AAME Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 9.78 | 9.56 | 9.78 | 9.21 | 9.15 | |
| Net income per share | -0.02 | 0.6 | 0.21 | 0.07 | -0.01 | |
| Operating cash flow per share | -0.09 | 0.44 | 0.05 | 0.32 | 0.13 | |
| Free cash flow per share | -0.09 | 0.43 | 0.05 | 0.31 | 0.12 | |
| Cash per share | 12.11 | 13.38 | 14.01 | 11.65 | 1.47 | |
| Book value per share | 5.84 | 7.1 | 6.93 | 5.01 | 5.26 | |
| Tangible book value per share | 16.85 | 17.98 | 17.94 | 4.89 | 5.13 | |
| Share holders equity per share | 5.84 | 7.1 | 6.93 | 5.01 | 5.26 | |
| Interest debt per share | 1.77 | 1.78 | 1.77 | 1.85 | 2.01 | |
| Market cap | 39.91M | 42.11M | 49.98M | 47.71M | 49.99M | |
| Enterprise value | 60.75M | 56.53M | 58.97M | 54.6M | 61.24M | |
| P/E ratio | -103.39 | 3.46 | 11.68 | 31.29 | -292.34 | |
| Price to sales ratio | 0.2 | 0.22 | 0.25 | 0.25 | 0.27 | |
| POCF ratio | -22.09 | 4.69 | 45.94 | 7.39 | 19.07 | |
| PFCF ratio | -21.27 | 4.82 | 50.95 | 7.54 | 19.67 | |
| P/B Ratio | 0.34 | 0.29 | 0.35 | 0.47 | 0.47 | |
| PTB ratio | 0.34 | 0.29 | 0.35 | 0.47 | 0.47 | |
| EV to sales | 0.31 | 0.29 | 0.3 | 0.29 | 0.33 | |
| Enterprise value over EBITDA | 152.26 | 3.45 | 9.37 | 13.49 | -108.39 | |
| EV to operating cash flow | -33.62 | 6.3 | 54.2 | 8.46 | 23.36 | |
| EV to free cash flow | -32.38 | 6.47 | 60.11 | 8.63 | 24.09 | |
| Earnings yield | -0.01 | 0.29 | 0.09 | 0.03 | 0 | |
| Free cash flow yield | -0.05 | 0.21 | 0.02 | 0.13 | 0.05 | |
| Debt to equity | 0.28 | 0.24 | 0.25 | 0.35 | 0.35 | |
| Debt to assets | 0.09 | 0.09 | 0.09 | 0.1 | 0.1 | |
| Net debt to EBITDA | 52.24 | 0.88 | 1.43 | 1.7 | -19.92 | |
| Current ratio | 5.89 | 6.46 | 5.54 | 14.37 | 0.8 | |
| Interest coverage | -0.28 | 9.58 | 3.81 | 1.62 | -0.17 | |
| Income quality | 4.68 | 0.74 | 0.25 | 4.23 | -15.33 | |
| Dividend Yield | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | |
| Payout ratio | -2.08 | 0.03 | 0.19 | 0.53 | -4.72 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Capex to operating cash flow | 0.04 | -0.03 | -0.1 | -0.02 | -0.03 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | -0.07 | -0.24 | -0.11 | -0.14 | -0.12 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.58 | 9.75 | 5.72 | 2.9 | 1 | |
| ROIC | 0 | 0.07 | 0.02 | 0.02 | 0 | |
| Return on tangible assets | 0 | 0.03 | 0.01 | 0 | 0 | |
| Graham Net | 11.48 | 12.54 | 12.89 | -7.13 | -10.97 | |
| Working capital | 241.32M | 278.95M | 268.88M | 26.85M | -13.73M | |
| Tangible asset value | 341.34M | 367.6M | 366M | 99.65M | 104.73M | |
| Net current asset value | 256.9M | 294.98M | 294.38M | -236.01M | -200.23M | |
| Invested capital | 0.28 | 0.24 | 0.25 | 0.35 | 0.35 | |
| Average receivables | 43.3M | 50.93M | 49.49M | 41.84M | 20.65M | |
| Average payables | 11.79M | 25M | 25.94M | 25.97M | 25.64M | |
| Average inventory | -13.01M | -37.45M | -45.16M | -169.75M | -149.03M | |
| Days sales outstanding | 83.38 | 105.75 | 77.51 | 80.25 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 4.38 | 3.45 | 4.71 | 4.55 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0 | 0.08 | 0.03 | 0.01 | 0 | |
| Capex per share | 0 | -0.01 | -0.01 | -0.01 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 2.22 | 2.27 | 2.41 | 2.19 | 2.29 | |
| Net income per share | 0.05 | -0.07 | 0.09 | 0.09 | -0.11 | |
| Operating cash flow per share | 0.43 | -0.57 | 0.33 | 0.07 | 0.3 | |
| Free cash flow per share | 0.43 | -0.57 | 0.33 | 0.07 | 0.3 | |
| Cash per share | 11.65 | 11.35 | 11.41 | 1.19 | 1.47 | |
| Book value per share | 5.01 | 5.11 | 5.07 | 4.84 | 5.26 | |
| Tangible book value per share | 4.89 | 4.99 | 4.95 | 4.72 | 5.26 | |
| Share holders equity per share | 5.01 | 5.11 | 5.07 | 4.84 | 5.26 | |
| Interest debt per share | 1.79 | 1.84 | 1.84 | 1.84 | 1.9 | |
| Market cap | 47.71M | 50M | 39.38M | 39.38M | 49.99M | |
| Enterprise value | 54.6M | 73.19M | 51.87M | 52.21M | 61.24M | |
| P/E ratio | 11.4 | -8.64 | 5.65 | 5.6 | -5.61 | |
| Price to sales ratio | 1.05 | 1.08 | 0.8 | 0.88 | 1.07 | |
| POCF ratio | 5.48 | -4.31 | 5.87 | 29.1 | 8.11 | |
| PFCF ratio | 5.49 | -4.28 | 5.87 | 29.25 | 8.11 | |
| P/B Ratio | 0.47 | 0.48 | 0.38 | 0.4 | 0.47 | |
| PTB ratio | 0.47 | 0.48 | 0.38 | 0.4 | 0.47 | |
| EV to sales | 1.21 | 1.58 | 1.05 | 1.17 | 1.31 | |
| Enterprise value over EBITDA | 24.46 | -68.53 | 23.4 | 24.42 | 467.47 | |
| EV to operating cash flow | 6.28 | -6.3 | 7.73 | 38.59 | 9.93 | |
| EV to free cash flow | 6.29 | -6.27 | 7.74 | 38.79 | 9.94 | |
| Earnings yield | 0.02 | -0.03 | 0.04 | 0.04 | -0.04 | |
| Free cash flow yield | 0.18 | -0.23 | 0.17 | 0.03 | 0.12 | |
| Debt to equity | 0.35 | 0.35 | 0.36 | 0.37 | 0.35 | |
| Debt to assets | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Net debt to EBITDA | 3.08 | -21.71 | 5.63 | 6 | 85.9 | |
| Current ratio | 138.82 | 4.52 | 8.08 | 7.92 | 0.8 | |
| Interest coverage | 3.06 | -1.67 | 2.75 | 2.52 | 0 | |
| Income quality | 8.32 | 8.03 | 3.85 | 0.77 | -2.77 | |
| Dividend Yield | 0.01 | 0 | 0 | 0.01 | 0.01 | |
| Payout ratio | 0.38 | 0 | 0 | 0.23 | -0.18 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.64 | |
| Capex to operating cash flow | 0 | 0.01 | 0 | -0.01 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | -0.07 | -0.31 | -0.05 | -0.04 | -0.04 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 2.41 | 2.86 | 3.12 | 3.06 | 3.59 | |
| ROIC | 0.01 | -0.01 | 0.01 | 0.01 | 0 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | -0.02 | |
| Graham Net | -1 | -6.44 | -7.61 | -12.33 | -10.98 | |
| Working capital | 276.88M | 10.55M | 21.25M | 20.9M | -13.73M | |
| Tangible asset value | 99.65M | 101.84M | 100.94M | 96.2M | -123M | |
| Net current asset value | 14.02M | -235.67M | -245.22M | -238.95M | -200.23M | |
| Invested capital | 0.35 | 0.35 | 0.36 | 0.37 | 0.35 | |
| Average receivables | 44.23M | 38.89M | 44.78M | 49.81M | 23.26M | |
| Average payables | 24.94M | 23.85M | 22.33M | 23.78M | 24.47M | |
| Average inventory | -24.01M | -165.13M | -299.49M | -206.31M | -47.93M | |
| Days sales outstanding | 82.18 | 70.94 | 97.13 | 93.91 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 1.1 | 1.27 | 0.93 | 0.96 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.01 | -0.01 | 0.02 | 0.02 | -0.02 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
AAME Frequently Asked Questions
What is Atlantic American Corporation stock symbol ?
Atlantic American Corporation is a US stock , located in Atlanta of Ga and trading under the symbol AAME
What is Atlantic American Corporation stock quote today ?
Atlantic American Corporation stock price is $1.95 today.
Is Atlantic American Corporation stock public?
Yes, Atlantic American Corporation is a publicly traded company.
Company Profile
- Volume Average 7.05K
- Market Capitalization 44.68M
- Employee 154
- CEO Mr. Hilton Hatchett Howell Jr.
- Headquarters Atlanta,GA,US
- IPO Date 1980-03-17
-
Website
https://www.atlam.com 
Atlantic American Corporation, through its subsidiaries, provides life and health, and property and casualty insurance products in the United States. The company operates through American Southern and Bankers Fidelity segments. It offers property and casualty insurance products, including business automobile insurance coverage for state governments, local municipalities, and other motor pools and fleets; and inland marine and general liability insurance products. The company also provides surety bond coverage for subdivision construction, school bus contracts, as well as performance and payment bonds. In addition, the company provides individual and group whole life insurance, as well as medicare supplement insurance products; and other accident and health insurance coverages, include various individual and group policies for the payment of standard benefits for the treatment of diagnosed cancer and other critical illnesses, as well as various other policies, such as short-term nursing facility care, accident expense, hospital indemnity, and disability coverages. It markets its products through independent agents and brokers. The company was founded in 1937 and is headquartered in Atlanta, Georgia.
